Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Opus Genetics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 35 | 1 | 41 | +7 |
| Shares | 3.10M | 30.0K | 3.46M | +387.5K (+12.6%) |
| Value | $10.9M | $110.0K | $13.0M | +$2.20M (+20.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Opus Genetics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Knoll Capital Management, LLC | 100,000 | $375.0K | 0.63% |
| Trust Co of Toledo NA | 26,000 | $97.5K | 0.02% |
| Occudo Quantitative Strategies LP | 19,623 | $73.6K | 0.01% |
| Captrust Financial Advisors | 19,501 | $73.1K | 0.00% |
| Cornerstone Capital, Inc. | 16,357 | $61.3K | 0.01% |
| Bank of New York Mellon Corp | 16,350 | $61.3K | 0.00% |
| United Bank | 11,800 | $44.3K | 0.01% |
| Kestra Private Wealth Services, LLC | 10,000 | $37.5K | 0.00% |
| National Bank of Canada | 2,000 | $7.50K | 0.00% |
| Hartford Financial Management Inc. | 1,000 | $3.75K | 0.00% |
| UBS Group AG | 564 | $2.12K | 0.00% |
Sold out (4)
Institutions that held Opus Genetics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Charles Schwab Investment Management Inc | 14,928 | $52.7K |
| Capital Analysts, LLC | 1,636 | $6.00K |
| First Manhattan Co | 600 | $2.12K |
| Bank of America Corp | 46 | $162 |
Not filed for Q1 2023 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 30,000 | $110.0K |